Butyl Alcohol

Butyl Alcohol

SCHEMBL11287694

CCCCO.O=CC(Cl)(Cl)Cl

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
SMN1; SMN2 Q16637 1/20 0.46
TSHR P16473 5/20 0.43
LMNA P02545 2/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TP53 P04637 1/20 0.33
FDPS P14324 2/20 0.32
ADH1B P00325 2/20 0.32
ADH1C P00326 2/20 0.32
ADH1A P07327 2/20 0.32
ADH7 P40394 2/20 0.32
EPHX1 P07099 1/20 0.31
ADH4 P08319 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyl Alcohol SCHEMBL3694445 0.81 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
Trichloroethane SCHEMBL10952212 0.78 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
Butyl Alcohol SCHEMBL1052989 0.78
Butyl Alcohol SCHEMBL5963005 0.78
Ethylene Glycol SCHEMBL9120710 0.78 TSHR (0.36) TSHR
Butyl Alcohol SCHEMBL1305605 0.78
Butyl Alcohol SCHEMBL1193596 0.78 ALDH1A1 (0.92) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
Butyl Alcohol SCHEMBL18281525 0.78 ALDH1A1 (0.92) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
Butyl Alcohol SCHEMBL7028948 0.78 ALDH1A1 (0.92) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
Butyl Alcohol SCHEMBL29044530 0.78 ALDH1A1 (0.92) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210015777-A1 HEALING TOPICAL COMPOSITION FLORENGALE, LLC 2021-01-21 US disclosed
US-10682324-B2 Healing topical composition FLORENGALE, LLC (US) 2020-06-16 US disclosed
US-20180015060-A1 HEALING TOPICAL COMPOSITION FLORENGALE, LLC 2018-01-18 US disclosed
EP-3250196-A1 HEALING TOPICAL COMPOSITION Florengale, LLC (US) 2017-12-06 EP disclosed
WO-2016123223-A1 HEALING TOPICAL COMPOSITION FLORENGALE, LLC (US) 2016-08-04 WO disclosed
US-4323467-A POLYOXYALKYLENE ETHYLENEDIAMINE NONIONIC SURFACTANT SYNTEX (U.S.A.) INC. (US) 1982-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210015777-A1 HEALING TOPICAL COMPOSITION CUTA, CSDE1, SRI ALDH1A1 3111/4885SMN1; SMN2 2843/4885TSHR 4877/4885
US-10682324-B2 Healing topical composition CUTA, CSDE1, SRI ALDH1A1 3111/4885SMN1; SMN2 2843/4885TSHR 4877/4885
US-20180015060-A1 HEALING TOPICAL COMPOSITION CUTA, CSDE1, SRI ALDH1A1 3111/4885SMN1; SMN2 2843/4885TSHR 4877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.